Track topics on Twitter Track topics that are important to you
Brokerages predict that Impax Laboratories, Inc. will announce $198.42 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Impax Laboratories' earnings, with the lowest sales estimate coming in at $192.52 million and the highest estimate coming in at $204.30 million.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...